StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.10+0.05 (+0.71%)

Close on Nov 18, 2026Market cap $195.97MP/E –Yield –

Precision BioSciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Precision BioSciences's operating income for the twelve months ending Jun 30, 2026 was -$36.40M. For fiscal 2025 it was -$52.15M. The highest annual figure on record is -$26.16M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$52.15M–
FY2024Dec 31, 2024-$26.16M–
FY2023Dec 31, 2023-$43.74M–
FY2022Dec 31, 2022-$62.31M–
FY2021Dec 31, 2021-$39.38M–
FY2020Dec 31, 2020-$109.83M–
FY2019Dec 31, 2019-$87.20M–
FY2018Dec 31, 2018-$47.91M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$19.16M–
Q1 FY2026Mar 31, 2026-$9.08M–
Q4 FY2025Dec 31, 2025$12.51M–
Q3 FY2025Sep 30, 2025-$20.67M–
Q2 FY2025Jun 30, 2025-$21.88M-190.6%
Q1 FY2025Mar 31, 2025-$22.11M–
Q4 FY2024Dec 31, 2024-$24.85M–
Q3 FY2024Sep 30, 2024-$21.28M–
Q2 FY2024Jun 30, 2024$24.15M–
Q1 FY2024Mar 31, 2024-$4.19M–
Q4 FY2023Dec 31, 2023-$14.89M–
Q3 FY2023Sep 30, 2023-$12.36M–
Q2 FY2023Jun 30, 2023-$3.13M–
Q1 FY2023Mar 31, 2023-$13.35M–
Q4 FY2022Dec 31, 2022-$12.11M–
Q3 FY2022Sep 30, 2022-$14.68M–
Q2 FY2022Jun 30, 2022-$29.55M-236.6%
Q1 FY2022Mar 31, 2022-$27.34M–
Q4 FY2021Dec 31, 2021-$30.72M–
Q3 FY2021Sep 30, 2021-$11.54M–
Q2 FY2021Jun 30, 2021$21.63M–
Q1 FY2021Mar 31, 2021-$18.74M–
Q4 FY2020Dec 31, 2020-$23.48M–
Q3 FY2020Sep 30, 2020-$26.04M–
Q2 FY2020Jun 30, 2020-$32.81M–
Q1 FY2020Mar 31, 2020-$27.50M–
Q4 FY2019Dec 31, 2019-$21.86M–
Q3 FY2019Sep 30, 2019-$21.98M–
Q2 FY2019Jun 30, 2019-$23.87M–
Q1 FY2019Mar 31, 2019-$19.49M–
Q4 FY2018Dec 31, 2018-$16.11M–
Q3 FY2018Sep 30, 2018-$10.45M–
Q2 FY2018Jun 30, 2018-$12.13M–
Q1 FY2018Mar 31, 2018-$9.24M–

More Precision BioSciences figures

See a number that looks wrong?